SCHEMBL13798616

SCHEMBL13798616

Cc1cc(-c2ccc(C(=O)O)cc2)cc(C)c1Oc1nc(Nc2ccc(N)cc2)nc2c1ncn2C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 2/20 0.43
▸ CYP2C19 P33261 2/20 0.43
▸ PIN1 Q13526 1/20 0.41
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ BTK Q06187 1/20 0.39
▸ RORC P51449 5/20 0.38
▸ JAK2 O60674 4/20 0.37
▸ JAK1 P23458 1/20 0.37
▸ TYK2 P29597 1/20 0.37
▸ JAK3 P52333 1/20 0.37
▸ PDE5A O76074 1/20 0.36
▸ ABCC3 O15438 1/20 0.36
▸ ESR1 P03372 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ PGR P06401 1/20 0.36
▸ CHRM2 P08172 1/20 0.36
▸ ABCB1 P08183 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13798619 0.92 CYP2C9 (0.44) CYP2C9CYP2C19RAB9ASMN1; SMN2RORC
SCHEMBL4110938 0.89 CYP2C9 (0.55) CYP2C9CYP2C19NPC1RAB9ASMN1; SMN2
SCHEMBL11947247 0.87 CYP2C9 (0.39) CYP2C9CYP2C19NPC1RAB9APDE5A
SCHEMBL10256417 0.86 CYP2C9 (0.43) CYP2C9CYP2C19PIN1NPC1RAB9A
SCHEMBL11947965 0.86 CYP2C9 (0.41) CYP2C9CYP2C19JAK2JAK1TYK2
SCHEMBL13798659 0.85 CYP2C9 (0.38) CYP2C9CYP2C19PIN1JAK2JAK1
SCHEMBL10254255 0.84 MAPK14 (0.38) CYP2C9CYP2C19JAK2JAK1TYK2
SCHEMBL4113576 0.83 CYP2C9 (0.56) CYP2C9CYP2C19JAK2JAK1TYK2
SCHEMBL10256174 0.82 ADORA1 (0.37) CYP2C9CYP2C19JAK2JAK1TYK2
SCHEMBL13561273 0.82 CYP2C9 (0.55) CYP2C9CYP2C19NPC1RAB9AJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009079412-A2 REVERSE TRANSCRIPTASE INHIBITORS ARDEA BIOSCIENCES INC. (US) 2009-06-25 — — WO disclosed
Send feedback